spacer
home > ict > spring 2016 > driven by results: part 2
PAY PER VIEW SERVICE

 

Dear guest!

article: Driven by Results: Part 2
format: Adobe Acrobat PDF file
cost: £

spacer

 
News and Press Releases

Pioneering a New Era of Cell Therapy Manufacturing

Aug 09 2022: Following its successful inspection, our Memphis cell therapy manufacturing facility is paving the way in the cell and gene therapy industry as the first contract development and manufacturing organization (CDMO) in North America to be awarded a commercial GMP license to produce allogeneic cell therapy drug products from the European Medicines Agency (EMA).
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement